Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "MEA"

2058 News Found

Life sciences firms move from AI pilots to scaled adoption, finds KPMG Global Tech Report 2026
Digitisation | June 17, 2026

Life sciences firms move from AI pilots to scaled adoption, finds KPMG Global Tech Report 2026

Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value


Jaslok Hospital performs advanced robotic surgery to remove early rectal cancer
Hospitals | June 17, 2026

Jaslok Hospital performs advanced robotic surgery to remove early rectal cancer

Robotic TAMIS procedure helps 75-year-old patient avoid rectum removal and permanent stoma, enabling faster recovery and preserving quality of life


We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids
Medical Device | June 16, 2026

FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids

Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes


Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial
Clinical Trials | June 16, 2026

Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial

The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor


Roche wins FDA approval for first PTEN-loss companion diagnostic in prostate cancer
News | June 16, 2026

Roche wins FDA approval for first PTEN-loss companion diagnostic in prostate cancer

The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer


OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI
R&D | June 16, 2026

OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI

The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months


Cryoviva brings advanced PrepaCyte-CB cord blood processing technology to India
Healthcare | June 16, 2026

Cryoviva brings advanced PrepaCyte-CB cord blood processing technology to India

Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential


Cohere Health’s Global Innovation Centre recognized as impactful at ET Edge GCC Summit
Healthcare | June 15, 2026

Cohere Health’s Global Innovation Centre recognized as impactful at ET Edge GCC Summit

Award highlights Hyderabad-based innovation hub’s role in advancing healthcare technology, clinical intelligence, and global operational excellence


Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio
Drug Approval | June 14, 2026

Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio

The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream